Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative indomethacin suppositories for prevention of post-pancreatectomy acute pancreatitis after pancreaticoduodenectomy
ChiCTR2500098972Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Post-pancreatectomy Acute Pancreatitis (PPAP) comparing Indomethacin Group with Placebo Group (2 arms). Primary endpoint: Incidence of post-pancreaticoduodenectomy acute pancreatitis. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
indomethacin
03
Conditions
Post-pancreatectomy Acute Pancreatitis (PPAP)
Beyond the preview
Go deeper on ChiCTR2500098972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098972.